Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo (Q34392953)

1 August 2017

title

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

1 reference

2

Glenn M Eisen

1 reference

1 August 2017

Jay L Goldstein

1

1 reference

1 August 2017

Blair Lewis

3

1 reference

1 August 2017

Ian M Gralnek

4

1 reference

1 August 2017

Steve Zlotnick

5

1 reference

1 August 2017

John G Fort

6

1 reference

1 August 2017

Investigators

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Clinical Gastroenterology and Hepatology

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

133-141

1 reference

Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Small bowel enteroscopy in undiagnosed gastrointestinal blood loss

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Anemia Due to Nonspecific Ileal Ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Review article: The advent of capsule endoscopy--a not-so-futuristic approach to obscure gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Valdecoxib does not impair platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Capsule endoscopy in patients with suspected Crohn's disease and negative endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Wireless capsule video endoscopy is a superior diagnostic tool in comparison to barium follow-through and computerized tomography in patients with suspected Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

Diagnosing small bowel Crohn's disease with wireless capsule endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900619-6

7 January 2021

10.1016/S1542-3565(04)00619-6

Identifiers

DOI

1 reference

1 August 2017

1 reference